COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ study #86 of 260
7/14 Late treatment study
Trullàs et al., Research Square, doi:10.21203/rs.3.rs-39421/v1 (Preprint)
High in-hospital mortality due to COVID-19 in a community hospital in Spain: a prospective observational study
Source   PDF   Share   Tweet
Retrospective 100 hospitalized patients in Spain showing lower mortality with HCQ+AZ.

Trullàs et al., 7/14/2020, retrospective, Spain, Europe, preprint, median age 75.0, 8 authors.
risk of death, 35.6% lower, RR 0.64, p = 0.12, treatment 20 of 66 (30.3%), control 16 of 34 (47.1%).

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit